Skip to main navigation Skip to search Skip to main content

Transforming growth factor-β1 potentiates amyloid-β generation in astrocytes and in transgenic mice

  • Sylvain Lesné
  • , Fabian Docagne
  • , Cecília Gabriel
  • , Géraldine Liot
  • , Debomoy K. Lahiri
  • , Luc Buée
  • , Laurent Plawinski
  • , André Delacourte
  • , Eric T. MacKenzie
  • , Alain Buisson
  • , Denis Vivien

Research output: Contribution to journal › Article › peer-review

Abstract

Accumulation of the amyloid-β peptide (Aβ) in the brain is crucial for development of Alzheimer's disease. Expression of transforming growth factor-β1 (TGF-β1), an immunosuppressive cytokine, has been correlated in vivo with Aβ accumulation in transgenic mice and recently with Aβ clearance by activated microglia. Here, we demonstrate that TGF-β1 drives the production of Aβ40/42 by astrocytes leading to Aβ production in TGF-β1 transgenic mice. First, TGF-β1 induces the overexpression of the amyloid precursor protein (APP) in astrocytes but not in neurons, involving a highly conserved TGF-β1-responsive element in the 5′-untranslated region (+54/+74) of the APP promoter. Second, we demonstrated an increased release of soluble APP-β which led to TGF-β1-induced Aβ generation in both murine and human astrocytes. These results demonstrate that TGF-β1 potentiates Aβ production in human astrocytes and may enhance the formation of plaques burden in the brain of Alzheimer's disease patients.

Original languageEnglish (US)
Pages (from-to)18408-18418
Number of pages11
JournalJournal of Biological Chemistry
Volume278
Issue number20
DOIs
StatePublished - May 16 2003

Fingerprint

Dive into the research topics of 'Transforming growth factor-β1 potentiates amyloid-β generation in astrocytes and in transgenic mice'. Together they form a unique fingerprint.

Cite this